NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Alcanza Clinical Research's Acquisition of Tampa Bay Medical Research
TL;DR
Alcanza Clinical Research gains a competitive edge by acquiring TBMR's established network and expertise, expanding its national footprint and enhancing clinical trial capabilities.
Alcanza acquires TBMR, integrating its 40-year legacy, 600+ trials, and 5000 sq ft facilities to create a scalable clinical research network with enhanced operational excellence.
This acquisition broadens access to innovative treatments for patients, especially underrepresented communities, by combining local expertise with national resources to improve healthcare outcomes.
Alcanza's acquisition of TBMR merges four decades of medical research with modern infrastructure, accelerating clinical trials for life-changing therapies across diverse regions.
Found this article helpful?
Share it with your network and spread the knowledge!
Alcanza Clinical Research has acquired Tampa Bay Medical Research (TBMR), an independent clinical research center with nearly four decades of experience in advancing medical science and patient care.
The acquisition was announced on January 05, 2026.
Carlos Orantes, CEO of Alcanza Clinical Research, and Dr. Sureka Bollepalli, CEO and Medical Director of Tampa Bay Medical Research, are the key leaders involved in this partnership.
Founded in 1984, TBMR has completed over 600 clinical trials across broad therapeutic areas for more than 70 sponsors, with facilities totaling over 5000 sq ft in Clearwater and Largo, Florida, and a reputation for operational excellence led by board-certified endocrinologist Dr. Sureka Bollepalli.
This acquisition represents a significant milestone in Alcanza's mission to expand its national footprint while preserving local expertise and personalized care, allowing the combined organization to accelerate clinical research and broaden access to innovative treatment opportunities.
By integrating TBMR's operational excellence and community presence with Alcanza's scalable infrastructure and strategic partnerships, the combined organization aims to strengthen patient support, deepen community engagement, expand access to high-quality clinical research, and advance care to improve lives.
TBMR has facilities in Clearwater and Largo, Florida, totaling over 5000 sq ft.
Alcanza Clinical Research is an integrated network focused on bringing clinical trial opportunities to all patients, especially underrepresented communities, with 25 dedicated research units and additional integrated specialty clinic sites throughout the Southeast, Northeast, Southwest, Midwest, and Puerto Rico.
You can visit their website at https://alcanzaclinical.com for more information.
Curated from 24-7 Press Release
